Accelera Innovations

Accelera Innovations EBITDA Growth YoY

The Year-over-Year EBITDA Growth of Accelera Innovations (ACNV) as of Oct 31, 2026 is 85.54 %. In the previous year, Year-over-Year EBITDA Growth was 58.69 % — a change of 45.74% (higher).

EBITDA Growth YoY

85.54 %

YoY

45.74%

Last updated:

Year-over-Year EBITDA Growth of Accelera Innovations is 2016 85.54 % . Year-over-Year EBITDA Growth of Accelera Innovations was 2015 58.69 % . It decreases by 45.74% higher compared to the previous year.

The Accelera Innovations EBITDA Growth YoY history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA Growth YoY
Date
EBITDA Growth YoY
Jan 1, 2015
58.69 USD
Jan 1, 2016
85.54 USD
The Accelera Innovations EBITDA Growth YoY history
YEAREBITDA Growth YoYYoY
85.54 %+45.74%
58.69 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Accelera Innovations Stock analysis

What does Accelera Innovations do? Accelera Innovations, Inc. generates revenue through its subsidiary SCI Home Health, Inc., operating as Advance Lifecare Home Health, which provides personal care services to patients in the Chicago, Illinois area. The company focuses on acquiring businesses in the post-acute care patient services and information technology services sectors, with SCI Home Health representing its primary healthcare service offering. Revenue is derived from healthcare service contracts within the post-acute care segment, targeting patients requiring ongoing care after hospitalization. The company's business model centers on strategic acquisitions within the healthcare services industry, specifically targeting post-acute care providers and technology service firms. SCI Home Health, Inc. serves as the operational vehicle for delivering personal care services, while the company's acquisition strategy aims to expand its presence in the healthcare sector through targeted investments in complementary businesses. The firm's revenue streams are primarily tied to the delivery of home health services under the Advance Lifecare Home Health brand in the Chicago metropolitan area. Accelera Innovations is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Accelera Innovations stock

Year-over-Year EBITDA Growth of Accelera Innovations is 85.54 % in 2016.

On Eulerpool you can find the complete historical development of Year-over-Year EBITDA Growth Accelera Innovations since 2006 – with annual values, charts, and detailed analysis.

EBITDA growth measures the percentage change in EBITDA compared to the prior year. It shows changes in operating cash earnings before capital structure effects.

To evaluate Year-over-Year EBITDA Growth's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Year-over-Year EBITDA Growth.

Year-over-Year EBITDA Growth's is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Year-over-Year EBITDA Growth's Accelera Innovations historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Growth — Accelera Innovations

Revenue GrowthRevenue CAGR 3YRevenue CAGR 5YRevenue CAGR 10YEarnings GrowthEPS GrowthEBIT GrowthEBIT CAGR 3YEBIT CAGR 5YEBIT CAGR 10YDividend GrowthFCF GrowthBook Value GrowthEarnings CAGR 3YEarnings CAGR 5YEarnings CAGR 10YEPS CAGR 3YEPS CAGR 5YEBITDA Growth YoYEBITDA CAGR 3YEBITDA CAGR 5YGross Profit GrowthOCF Growth YoYEmployee GrowthDividend CAGR 3YDividend CAGR 5YDividend CAGR 10YAsset GrowthEquity GrowthDebt GrowthCapEx GrowthFCF CAGR 3YFCF CAGR 5YMarket Cap GrowthShare Count Growth

All Key Metrics — Accelera Innovations